| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
Transient receptor potential (TRP) cation channels: rewarding unique proteins.
|
2007
|
1.00
|
|
2
|
Natural history of Plasmodium falciparum malaria and determining factors of the acquisition of antimalaria immunity in two endemic areas, Dielmo and Ndiop (Senegal).
|
2000
|
0.95
|
|
3
|
Modulation of Kupffer cell activity: physio-pathological consequences on hepatic metabolism.
|
2004
|
0.94
|
|
4
|
Pathobiology of pulmonary arterial hypertension.
|
2004
|
0.85
|
|
5
|
Revelations from the unconscious: studying residual brain function in coma and related states.
|
2008
|
0.84
|
|
6
|
[Apoptosis induced by bovine herpesvirus 1].
|
1998
|
0.83
|
|
7
|
[HLA-G: from feto-maternal tolerance to organ grafting].
|
2009
|
0.83
|
|
8
|
[Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
|
2006
|
0.82
|
|
9
|
Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
|
2006
|
0.82
|
|
10
|
Circumsporozoite proteins of malaria parasites.
|
1989
|
0.82
|
|
11
|
Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies.
|
2004
|
0.82
|
|
12
|
[Mechanism of bone lengthening by the Ilizarov technique].
|
2001
|
0.81
|
|
13
|
[Physiology of the growth hormone in pregnancy and discovery of a human placental growth hormone].
|
1986
|
0.81
|
|
14
|
[Extra-membranous glomerulonephritis: from the experimental model to the human pathology of new-born and adult].
|
2008
|
0.81
|
|
15
|
Globalization of Chagas disease (American trypanosomiasis): the situation in Europe and Belgium.
|
2011
|
0.81
|
|
16
|
Radiotherapy systems using proton and carbon beams.
|
2008
|
0.81
|
|
17
|
[Is there still a place for bone allografts in orthopedic surgery in 2011?].
|
2011
|
0.80
|
|
18
|
[Acute methanol intoxication: physiopathology, prognosis and treatment].
|
2005
|
0.80
|
|
19
|
Quality genetic services for the population, now and in the future.
|
2010
|
0.80
|
|
20
|
[A new mechanism of tumor resistance to the immune system, based on tryptophan breakdown by indoleamine 2,3-dioxygenase].
|
2003
|
0.80
|
|
21
|
[Surgical biology of wound healing].
|
2001
|
0.80
|
|
22
|
[Antigenic variation and the problem of vaccines against African trypanosomes].
|
1995
|
0.80
|
|
23
|
[Correction of a diabetes mellitus type 1 on primate with encapsulated islet of pig pancreatic transplant].
|
2007
|
0.80
|
|
24
|
[Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy].
|
2011
|
0.79
|
|
25
|
[Is the prion abnormality going to involve immunology?].
|
2003
|
0.79
|
|
26
|
Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress").
|
2002
|
0.79
|
|
27
|
[Interferon-gamma, the TH1/TH2 paradigm in autoimmunity].
|
1998
|
0.79
|
|
28
|
[Developmental abnormalities of the human cerebral cortex: current findings and prospective studies].
|
1978
|
0.79
|
|
29
|
[Lyme disease: clinical and sero-epidemiological study of Borrelia burgdorferi infections in Belgium].
|
1990
|
0.79
|
|
30
|
Towards the selection of chickens resistant to Salmonella and Campylobacter infections.
|
2009
|
0.78
|
|
31
|
The emergence of the pandemic A/H1N1 2009 virus and its characteristics.
|
2009
|
0.78
|
|
32
|
[Ecogenetic aspects of acute side effects caused by angiotensin converting enzyme inhibitors].
|
2004
|
0.78
|
|
33
|
[Stromal proteases in the progression of breast cancer].
|
1997
|
0.78
|
|
34
|
[Study of the role of Clostridium perfringens in bovine enterotoxemia].
|
1999
|
0.78
|
|
35
|
Inherited dysregulation of the complement system.
|
2004
|
0.78
|
|
36
|
A role for sleep in the processing of memory traces. Contribution of functional neuroimaging in humans.
|
2004
|
0.78
|
|
37
|
AIDS pathogenesis: what have two decades of research taught us?
|
2004
|
0.78
|
|
38
|
[Trypanolytic factor of human serum].
|
2006
|
0.78
|
|
39
|
The Hh signaling pathway in cancer.
|
2007
|
0.78
|
|
40
|
[Alzheimer disease: cellular and molecular aspects].
|
2005
|
0.78
|
|
41
|
Vaccination strategies against influenza.
|
2009
|
0.78
|
|
42
|
Neuro-vascular link: from genetic insights to therapeutic perspectives.
|
2008
|
0.78
|
|
43
|
[Physiopathologic aspects of anemia and thrombocytopenia in children with cancers: the roles of erythropoietin and thrombopoietin].
|
2008
|
0.78
|
|
44
|
The genetics of human obesity: recent progress.
|
2001
|
0.77
|
|
45
|
[Role of PAI-1 plasminogen activator inhibitor in tumor invasion and angiogenesis].
|
2002
|
0.77
|
|
46
|
[Radioprotection and medical practice: progress, distress and treats].
|
2008
|
0.77
|
|
47
|
[Molecules of the family of aspartic proteinases in the placenta of ruminants: hormones or proteins?].
|
1994
|
0.77
|
|
48
|
[Role of interleukin-9 in asthma and allergic reactions].
|
2007
|
0.77
|
|
49
|
[European Agency for the Evaluation of Medicinal Products: five years experience].
|
2000
|
0.77
|
|
50
|
[Yersinia enterocolitica, an excellent model for the molecular study of the pathogenicity of invasive bacteria].
|
1987
|
0.77
|